| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/16/2007 | US20070189982 Diagnostics and treatments of Periodontal disease |
| 08/16/2007 | US20070189981 Porphorymonas gingivalis polypeptides and nucleotides |
| 08/16/2007 | US20070189964 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 08/16/2007 | US20070189963 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 08/16/2007 | US20070189962 Mutated anti-cd22 antibodies and immunoconjugates |
| 08/16/2007 | CA2641988A1 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa |
| 08/16/2007 | CA2641602A1 Peptide sequences and compositions |
| 08/16/2007 | CA2641555A1 Preferential inhibition of presenilin-1 |
| 08/16/2007 | CA2641310A1 Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 08/16/2007 | CA2641169A1 Antigenic gm-csf peptides and antibodies to gm-csf |
| 08/16/2007 | CA2638889A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 08/16/2007 | CA2638849A1 Antibodies that bind par-2 |
| 08/16/2007 | CA2638815A1 Yeast-based vaccine for inducing an immune response |
| 08/16/2007 | CA2638811A1 Protein formulations |
| 08/16/2007 | CA2638040A1 Treatment of metastatic breast cancer |
| 08/16/2007 | CA2637786A1 Compositions and methods for enhancing neuronal plasticity and regeneration |
| 08/16/2007 | CA2637775A1 Antibodies against secreted frizzled related protein-4 (sfrp-4 ) |
| 08/16/2007 | CA2636632A1 Novel viral vector |
| 08/16/2007 | CA2623729A1 Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic |
| 08/15/2007 | EP1818403A1 Mutant g genes of the trout viral haemorrhagic septicaemia virus (vhsv) and applications thereof |
| 08/15/2007 | EP1818343A2 Antibodies against human IL-12 |
| 08/15/2007 | EP1818342A2 Purified primate CTLA-8 antigens and related reagents |
| 08/15/2007 | EP1818341A2 Sheep lice, bovicula ovis, allergen treatment |
| 08/15/2007 | EP1818062A1 An anti HSP90 antibody |
| 08/15/2007 | EP1817584A2 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 08/15/2007 | EP1817409A1 Methods for cultivating lawsonia intracellularis |
| 08/15/2007 | EP1817344A2 ANTI-TNF ALPHA ANTIBODIES WHICH SELECTIVELY INHIBIT TNF ALPHA SIGNALLING THROUGH THE p55R |
| 08/15/2007 | EP1817341A2 Engineered antibodies and immunoconjugates |
| 08/15/2007 | EP1817327A1 Antigenic epitopes of interleukin-21, related antibodies and their use in medical field |
| 08/15/2007 | EP1817061A2 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 08/15/2007 | EP1817055A2 Ovr110 antibody compositions and methods of use |
| 08/15/2007 | EP1817054A1 Naturally occuring igm antibodies that bind lymphocytes |
| 08/15/2007 | EP1817053A1 Novel pharmaceutical composition useful for vaccines |
| 08/15/2007 | EP1817045A2 An oil-in-water nanoemulsion, a cosmetic composition and a cosmetic product comprising it, a process for preparing said nanoemulsion |
| 08/15/2007 | EP1539822B1 Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells |
| 08/15/2007 | EP1368372B1 Peptides having affinity for the gp120 viral protein and use thereof |
| 08/15/2007 | EP1137785B1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 08/15/2007 | EP1108023B1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 08/15/2007 | EP0981618B1 Anti-apo-2 antibody |
| 08/15/2007 | EP0784684B1 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES |
| 08/15/2007 | EP0752888B1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR |
| 08/15/2007 | EP0752874B1 Enhanced virus-mediated dna transfer |
| 08/15/2007 | CN1332029C Mutant recombinant allergens |
| 08/15/2007 | CN1331887C Lymphoma specific chimeric monoclonal antibody against HLA-DR10 |
| 08/15/2007 | CN1331885C Tumor antigen protein and peptide antigen in a tumor - testis antigens, the application to medication of hepatocellular cancer / lung cancer |
| 08/15/2007 | CN1331877C Recombinant helicobacter pylori outer-membrane protein 25 |
| 08/15/2007 | CN1331876C Recombinant helicobacter pylori blood group antigen adhesin |
| 08/15/2007 | CN1331535C Application of viscid serratia vaccine in preparing medicine for treating bronchial asthma |
| 08/15/2007 | CN1331534C Aquaculture creature disease controlling compound vaccine and its preparation method |
| 08/15/2007 | CN1331532C Botulinum toxin pharmaceutical compositions |
| 08/15/2007 | CN101018863A Mutant pneumolysin proteins |
| 08/15/2007 | CN101018810A Anti-synoviolin antibody |
| 08/15/2007 | CN101018808A Compositions and methods for regulation of tumor necrosis factor-alpha |
| 08/15/2007 | CN101018805A Reagents for diagnosis and therapy of latex allergy and method for the preparation of the same |
| 08/15/2007 | CN101018567A Induction of apoptosis in Toll-like receptor expressing tumor cells |
| 08/15/2007 | CN101018565A Methods for treating conditions associated with MASP-2 dependent complement activation |
| 08/15/2007 | CN101018564A Treatment of atherosclerosis |
| 08/15/2007 | CN101016547A Method of preparing ocean double RNA virus MABV recombination albumen and application thereof |
| 08/15/2007 | CN101016543A In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 08/15/2007 | CN101016542A Method of increasing yield of human papilloma virus L1 albumen pronucleus expression |
| 08/15/2007 | CN101016541A Method of producing brucella vaccine antigen protein |
| 08/15/2007 | CN101015693A Use of CD25 binding molecules in steroid-resistant patients. |
| 08/15/2007 | CN101015692A Molecular antigen array |
| 08/15/2007 | CN101015691A Recombinant phages influenza vaccine |
| 08/15/2007 | CN101015690A Development and application of wide spectrum influenza vaccine |
| 08/15/2007 | CN101015689A Tumour polypeptide vaccine based on angiotensin II |
| 08/15/2007 | CN101015688A Molecular antigen array |
| 08/15/2007 | CN101015687A Preparing technique for rapid extraction of antigastrin release tumor vaccine |
| 08/15/2007 | CN101015378A Health care beverage with human body immunity increasing function |
| 08/15/2007 | CN101015377A Health care water with human body immunity increasing function |
| 08/14/2007 | US7256282 Comprises nucleotide sequences coding parasite membrane protein for use in generating immunoglobulins to prevent equine protozoal myeloencephalitis (EPM); veterinary medicine |
| 08/14/2007 | US7256281 Recombinant P. falciparum merozoite protein-142 vaccine |
| 08/14/2007 | US7256273 Diagnosis of brain disorders; Alzheimer's disease; genetic engineered immunoglobulins |
| 08/14/2007 | US7256272 Separation of anticancer antibodies using cancer cell cytotoxicity; complexing antibodies; medical diagnosis |
| 08/14/2007 | US7256271 Cancerous disease modifying antibodies |
| 08/14/2007 | US7256270 Immunogen adherence inhibitor and method of making and using same |
| 08/14/2007 | US7256269 Immunogen adherence inhibitor and method of making and using same |
| 08/14/2007 | US7256265 Genetic engineered polypeptides |
| 08/14/2007 | US7256263 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies |
| 08/14/2007 | US7256254 For therapy and prophylaxis of myocarditis |
| 08/14/2007 | US7256253 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 08/14/2007 | US7256178 Physiologically active substances |
| 08/14/2007 | US7256043 Transfection complexes |
| 08/14/2007 | US7256038 Polypeptide display libraries and methods of making and using thereof |
| 08/14/2007 | US7256037 Modified vaccinia Ankara expressing p53 in cancer immunotherapy |
| 08/14/2007 | US7256036 Blocking receptor binding; gene therapy; gastrin releasing peptide |
| 08/14/2007 | US7256010 Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 08/14/2007 | US7255997 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 08/14/2007 | US7255986 Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets |
| 08/14/2007 | US7255868 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 08/14/2007 | US7255867 Group A streptococcal antigen combined with proteosome adjuvant; prevention or reduction of throat colonization; intranasal administration |
| 08/14/2007 | US7255866 Botulinum toxin therapy for fibromyalgia |
| 08/14/2007 | US7255865 Administering a Clostridium neurotoxin component using a needleless syringe to treat involunatary muscle contraction |
| 08/14/2007 | US7255864 Diagnostic reagent for hepatitis C virus infection |
| 08/14/2007 | US7255863 Group A streptococcal vaccines |
| 08/14/2007 | US7255862 ALVAC/FIV constructs |
| 08/14/2007 | US7255861 Preparations for inducing immunotolerance and uses therefor |
| 08/14/2007 | US7255860 Effective against resting pain, mechanically-induced pain and thermally-induced pain without inhibiting wound healing |
| 08/14/2007 | US7255859 Derived from the haemagglutinin of the human influenza virus and suitable for the detection and isolation of native haemagglutinin of the human influenza virus, of modified haemagglutinin or of haemagglutinin fusion proteins |
| 08/14/2007 | US7255858 Enhancing the efficacy of immunotherapies by supplementing with complement |